CSL Limited
CSL
株式のランク
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
株価
$138.58
時価総額
$66.50B
変化（1日）
0.72%
変化（1年）
-2.29%
国
AU
取引 CSL Limited (CSL)
カテゴリー
Healthcare
CSL Limited（CSL）の発行済株式数
June 2026 時点の発行済株式数 478.91M
CSL Limited の最新の財務報告および株価によると、現在の発行済株式数は 478.91M です。June 2024 の終わりには、同社は 483.01M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
CSL Limited（CSL）の発行済株式数の履歴（2000 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 478.91M | -1.03% |
| 2025 | 483.88M | 0.18% |
| 2024 | 483.01M | 0.17% |
| 2023 | 482.17M | 2.86% |
| 2022 | 468.76M | 3.05% |
| 2021 | 454.87M | 0.23% |
| 2020 | 453.81M | 0.20% |
| 2019 | 452.92M | 0.13% |
| 2018 | 452.35M | -0.65% |
| 2017 | 455.33M | -1.44% |
| 2016 | 462.00M | -2.08% |
| 2015 | 471.82M | -2.48% |
| 2014 | 483.82M | -2.97% |
| 2013 | 498.61M | -3.97% |
| 2012 | 519.23M | -3.94% |
| 2011 | 540.53M | -4.63% |
| 2010 | 566.78M | -4.78% |
| 2009 | 595.24M | 8.21% |
| 2008 | 550.11M | 0.44% |
| 2007 | 547.71M | 0.30% |
| 2006 | 546.08M | -7.12% |
| 2005 | 587.97M | 10.00% |
| 2004 | 534.52M | 11.94% |
| 2003 | 477.51M | 0.53% |
| 2002 | 474.99M | 5.89% |
| 2001 | 448.57M | 12.11% |
| 2000 | 400.11M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 253.90M | -46.98% |
US
|
|
| 396.00M | -17.31% |
US
|
|
| - | - |
CH
|
|
| 62.19M | -87.02% |
NL
|
|
| 0.00 | -100.00% |
BE
|
